BlueCrest Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,336
Closed -$380K 123
2024
Q1
$380K Sell
1,336
-1,603
-55% -$469K 0.02% 181
2023
Q4
$846K Buy
2,939
+1,198
+69% +$326K 0.03% 181
2023
Q3
$468K Buy
+1,741
New +$434K 0.02% 208
2020
Q1
Sell
-1,639
Closed -$395K 227
2019
Q4
$395K Sell
1,639
-4,321
-73% -$952K 0.03% 228
2019
Q3
$1.15M Buy
+5,960
New +$1.14M 0.08% 174
2019
Q2
Sell
-17,305
Closed -$3.29M 425
2019
Q1
$3.29M Buy
17,305
+1,409
+9% +$269K 0.13% 121
2018
Q4
$3.09M Sell
15,896
-15,157
-49% -$2.96M 0.16% 99
2018
Q3
$6.44M Sell
31,053
-25,668
-45% -$5.06M 0.17% 88
2018
Q2
$10.5M Buy
56,721
+27,744
+96% +$4.91M 0.27% 69
2018
Q1
$4.94M Buy
28,977
+5,906
+26% +$1.08M 0.15% 130
2017
Q4
$4.01M Sell
23,071
-18,731
-45% -$3.31M 0.11% 187
2017
Q3
$7.79M Buy
41,802
+39,274
+1,554% +$6.96M 0.32% 80
2017
Q2
$435K Buy
+2,528
New +$411K 0.02% 614
2016
Q4
Sell
-1,762
Closed -$294K 649
2016
Q3
$294K Buy
1,762
+342
+24% +$57.8K 0.01% 619
2016
Q2
$216K Buy
+1,420
New +$221K 0.01% 774
2016
Q1
Sell
-6,594
Closed -$1.07M 768
2015
Q4
$1.07M Buy
6,594
+1,497
+29% +$235K 0.04% 389
2015
Q3
$705K Sell
5,097
-1,698
-25% -$268K 0.02% 515
2015
Q2
$1.04M Buy
+6,795
New +$1.09M 0.03% 485
2015
Q1
Sell
-3,953
Closed -$630K 603
2014
Q4
$630K Buy
+3,953
New +$616K 0.02% 429

Other funds holding AMGN

BlueCrest Capital Management's AMGN Position: Q2 2024 in Review

BlueCrest Capital Management sold out of Amgen (AMGN) in Q2 2024, closing a stake of 1,336 shares — an estimated $380K sold.

BlueCrest Capital Management first reported a position in AMGN in Q4 2014 and held it in 19 quarters. The position peaked at $10.5M in Q2 2018. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • BlueCrest Capital Management reported no remaining Amgen position as of Q2 2024 after selling out during the quarter.
  • BlueCrest Capital Management sold 1,336 Amgen shares in Q2 2024, an estimated $380K.
  • BlueCrest Capital Management first reported a position in Amgen in Q4 2014 and held it in 19 quarters.
  • BlueCrest Capital Management's Amgen position peaked at $10.5M in Q2 2018.
  • 2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on BlueCrest Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.